https://www.indianpharmapost.com/shilpa-medicare-aims-for-us-approval-of-chemo-nausea-drug-188152026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/breakthrough-in-psa-taltz-plus-zepbound-show-major-gains-for-patients-with-obesity-188292026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/newron-secures-key-european-patent-for-schizophrenia-drug-evenamide-188282026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/addex-spin-out-neurosterix-launches-phase-1-trial-for-novel-schizophrenia-drug-188272026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/world-first-heart-bypass-without-opening-the-chest-achieved-by-nih-and-emory-team-188262026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/beone-medicines-wins-first-in-world-nod-for-sonrotoclax-in-china-188252026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/oculis-privosegtor-wins-fda-breakthrough-therapy-status-for-optic-neuritis-188242026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/iksuda-reports-promising-early-results-for-her2-targeted-therapy-in-oesophageal-cancer-188232026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/nimbus-therapeutics-and-eli-lilly-team-up-on-novel-obesity-therapy-188222026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/who-unveils-updated-hiv-guidelines-to-boost-treatment-save-lives-188212026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/gsk-reports-breakthrough-results-in-chronic-hepatitis-b-trials-188202026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/gsk-secures-european-nod-for-easier-to-use-shingrix-prefilled-syringe-188192026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/alkem-launches-innovative-hair-growth-support-therapy-kit-188182026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/imcd-opens-beauty-personal-care-laboratory-in-california-188172026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/granules-pharmaceuticals-secures-fda-tentative-approval-and-180-day-exclusivity-for-generic-dyanavel-xr-188162026-01-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/leeford-healthcare-bets-rs-200-crore-on-orthopedic-mobility-aids-188302026-01-09T00:00:00+05:30always0.9